These trials presented enhanced cellular uptake of nanoparticular systems due to pinocytosis and retention of anticancer drugs in in vitro tumor cells, followed by ATP depletion by Pluronic® block copolymer or direct binding of verapamil to P-gp on specific sites [54,56]. The gene discussed is PGP; the disease is neoplasm.